{"symbol":"BMY","fiscalQuarter":"Q2-2012","reportDate":"2012-07-25","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q2-2012","postBrief":{"headline":"Bristol Myers Squibb Misses on EPS \u2014 Stock Up 0.63%","keyNumbers":[{"metric":"EPS","actual":"$0.48","expected":"N/A","surprise":"-1.64%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management emphasized ongoing commitment to innovation and pipeline development.","They acknowledged challenges but expressed confidence in long-term growth."],"summary":"Overall, management conveyed a cautious optimism about the future. They highlighted their focus on maintaining a strong pipeline despite current challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report showed a slight miss on EPS, which may raise concerns among investors about profitability. However, the stock reacted positively, gaining 0.63%, likely due to management's focus on innovation and pipeline strength. The lack of revenue data and guidance leaves some uncertainty for future performance.","metaDescription":"Bristol Myers Squibb (BMY) Q2 2012 earnings: EPS missed. Stock up 0.63%. Full breakdown."}}